Philip Low: key obituary facts
Is Philip Low dead? Yes. Philip Low died on March 4, 2026, at age 78.
Cause of death: Philip Low's cause of death has not been publicly confirmed.
What was Philip Low known for?
Philip Low was an American chemist.
More about Philip Low
Born: August 8, 1947.
Philip Low, an American chemist and the Ralph C.
Corley Distinguished Professor of Chemistry at Purdue University, died March 4, 2026, at age 78. A prolific researcher, he contributed to numerous drug discoveries and was credited as one of the developers of Pluvicto.
Low also cofounded the biotechnology company Endocyte, later acquired by Novartis, and the biopharmaceutical company Novosteo, later purchased by Cortexyme. He received the American Chemical Society’s George & Christine Sosnovsky Award for Cancer Research.
Philip Stewart Low (August 8, 1947 – March 4, 2026) was an American scientist and the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. He was a prolific researcher whose work supported numerous drug discoveries and he was credited as one of the developers of Pluvicto. Low cofounded the biotechnology company Endocyte, which was later acquired by Novartis, as well as the biopharmaceutical company Novosteo, which was later purchased by Cortexyme.